Reports for CHEPLAPHARM ARZNEIMITTEL GMBH

Company Name

CHEPLAPHARM ARZNEIMITTEL GMBH

Totals

Shortage reports

48

Actual shortage: 7 (15%)
Anticipated shortage: 0 (0%)
Avoided shortage: 1 (2%)
Resolved: 40 (83%)

Discontinuation Reports

4

To be discontinued: 0 (0%)
Discontinued: 4 (100%)
Reversed: 0 (0%)

Late reports

4 (8%)

Overdue reports

4 (57%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
VEPESID 50MG CAPSULE Resolved 2018-12-20 2019-07-05 70228
VALCYTE 50MG POWDER FOR SOLUTION Resolved 2023-05-02 2023-11-05 191497
FUNGIZONE 50MG POWDER FOR SOLUTION Resolved 2017-07-20 2019-05-23 16534
FUNGIZONE 50MG POWDER FOR SOLUTION Resolved 2022-11-10 2023-02-14 174215
FUNGIZONE 50MG POWDER FOR SOLUTION Actual shortage 2024-03-08 2024-03-12 221737
INHIBACE PLUS 5MG 12.5MG TABLET Resolved 2021-01-04 2021-10-19 130792
INHIBACE 5MG TABLET Resolved 2020-05-13 2021-10-19 114894
SUPREFACT DEPOT 3 MONTHS 9.45MG IMPLANT Actual shortage 2023-10-24 2023-10-25 207981

Showing 41 to 48 of 48

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SUPREFACT 100MCG SOLUTION Discontinued 2021-12-13 2021-12-13 151039
XELODA 150MG TABLET Discontinued 2022-11-30 2022-12-01 176355
LOSEC 20MG TABLET (DELAYED-RELEASE) Discontinued 2021-11-19 2021-11-19 149669
XELODA 500MG TABLET Discontinued 2022-11-30 2022-12-01 176359

Showing 1 to 4 of 4